Therefore, it is reasonable to believe that obesity or diabetes caused by metabolic disorders inhibits AMPK-Nrf2 pathway activity, just as free fatty acid accumulation and high glucose environment are accompanied with oxidative stress damage and ROS accumulation (145). The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.